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Abstract 
A wearable personalized ventilation (PV) unit to reduce the risk from airborne 
disease contamination is reported. The PV unit consists of a nozzle, installed on a 
headset, which is used to locally exhaust the exhaled air before it mixes with the 
surroundings. Experiments at 22 °C were performed in a full-scale test room 
furnished as a double bed hospital room. A breathing thermal manikin with a 
realistic free convection flow around the body and breathing cycle was used to 
mimic a sick doctor. A second thermal manikin and a heated dummy were used to 
resemble two lying patients. The air exhaled by the doctor was mixed with tracer 
gas (R134 A) to mimic airborne pathogens. The PV nozzle was positioned frontally 
0.02 m from the mouth of the doctor exhausting 0.25 L/s air. The performance of the 
PV in combination with mixing background air distribution at 3 ACH was compared 
with the case of only mixing background air distribution at 3, 6 and 12 ACH. The 
use of the device showed a great potential in reducing the concentration of exhaled 
air in the room to the level measured under mixing ventilation alone at 12 ACH. The 
high potential to capture exhaled air, makes the wearable PV applicable as an 
efficient engineering control method that can reduce the spread of pathogen laden 
air from sick occupants in densely occupied spaces, i.e. cinemas, public 
transportation, office buildings etc.  
Keywords - wearable Personalized Ventilation; contaminant control; hospital 
ventilation; airborne cross-infection; full-scale measurements 
1. Introduction  
In hospitals ventilation is expected to remove efficiently the droplets 
nuclei from bio-aerosols which may contain pathogens and are generated 
from sick person (patient, staff or visitor) or from different medical activities. 
Thus the hospital ventilation systems should be designed differently from 
those in commercial and residential buildings, as in the former case the main 
sources of contamination (pathogens) may come from respiratory activities. 
Ventilation rates exceeding 12 ACH for airborne infection control in 
isolation rooms are recommended by guidelines and standards [1, 2, 3]. 
Ventilating at 12 ACH can reduce the pollutant concentration to 0.1% from 
the initial fraction in 35 min and to 0.01% in 47 min. However such elevated 
ventilation rates result in: 1) significantly increased energy consumption to 
transport and condition the air supplied; 2) increased investment and 
maintenance costs of the building due to oversizing of the HVAC 
components and larger spaces to accommodate them; 3) elevated risk of 
draught discomfort for occupants. Furthermore, when ventilating based on 
the volume of the occupied space neither the pathogen infectivity nor the 
number of infective sources (patients, medical staff members, etc.) present in 
the room is accounted for.  
An efficient way to evacuate the generated pathogens indoor is to 
capture them close to source origin. In hospitals this would mean at the 
breathing zone of the sick occupant. Incorporating localized ventilation at the 
hospital bed can ensure efficient extraction of respired flows by sick 
individuals and significant reduction of airborne pathogen spread indoors 
even at greatly reduced ventilation rates [4, 5, 6]. However this method will 
work as long as the sick occupant stays in bed. Another issue is that the 
doctor himself or visitors can be sick and can release airborne pathogens 
with expired air. In this case the localized bed incorporated ventilation will 
not be effective in reducing the airborne spread in the surroundings. 
Therefore a local exhaust orifice aesthetically incorporated into the 
mouthpiece of a headset could be used. It will capture the expired air directly 
at the breathing zone of the occupant. The captured air can be then cleansed 
and filtered via a miniaturized mobile unit containing a pump, filter and 
UVGI that can be attached to the clothing of the user similar to an iPod. The 
concept of using headset incorporated personalized ventilation (PV) is not 
new. Such wearable PV was used to supply clean air directly into the 
breathing zone of the occupant with great efficiency at flow rates lower than 
0.5 L/s [4, 7, 8, 9]. However, using the PV device to extract locally the 
respired air has not yet been investigated. 
In this paper results are presented showing the potential of such 
wearable PV unit used by doctor as local exhaust in a double bed hospital 
room to reduce the exposure levels to exhaled air for the patients. 
2. Method 
Experiments were designed and performed in a climate chamber with 
dimensions 4.75 m x 4.65 m x 2.60 m (W x L x H) furnished to simulate a 
hospital isolation room with two beds. The distance between the beds was set 
to 1.3 m. Five ceiling-mounted light fixtures (6 W each) provided the 
background lighting. The chamber was located in a larger hall, where the 
temperature was kept constant and equal to the air temperature in the test 
room. A dressed breathing thermal manikin (1.02 Clo) with realistic body 
size, shape and surface temperature distribution was used to resemble a 
“doctor” standing next to one of the two beds: 0.55 m away. The doctor was 
facing the patient. The manikin consisted of 17 sections. The manikin was 
equipped with an artificial lung [10] to simulate a breathing sick doctor. One 
full breathing cycle consisted of three steps and lasted 6 s: inhalation – 2.5 s, 
exhalation – 2.5 s and break – 1 s. The characteristics of the breathing cycle 
were: inhalation nose, exhalation mouth; tidal flow rate – 0.24 L/s (6 L/min) 
[11]. A second thermal manikin of 23 body segments was used to simulate a 
sick patient lying in the bed closest to the doctor. The manikin was dressed 
with patient pajamas of 0.38 Clo. Each manikin released 60 W sensible heat 
load on average. A heated dummy with simplified body geometry was used 
to mimic the second patient lying in the other bed. The two beds were placed 
in parallel and both patients were facing the ceiling. The layout of the set-up 
is shown in Fig. 1. 
 
Fig. 1  Experimental set-up and locations of the sampling points for the tracer gas 
concentration measurements; top view: I- exposed patient 1(EP1), II- exposed patient 2(EP2), 1 
– supply, 2 – exhaust over EP1, 3 – exhaust over EP2, 4 – mouth of EP1, 5 – mouth of EP2, 6 
– centre of the room 1.7 m above the floor, 7 – centre of the room 1.1 m above the floor, 8 – 
centre of the room 0.1 m above the room, 9 –left from EP2 1.7 m above the floor, 10 – at feet 
of EP1 1.7 m above the floor, 11 – at feet of EP1 1.1 m above the floor 
During all experiments overhead mixing ventilation was used. The 
supply air was 100% outdoor air with no recirculation. The supply diffuser 
was a square diffuser with an unperforated face plate with a 3-way-
discharge. Two square ceiling mounted diffusers with perforated face plate 
were used for exhausting the air from the room. They were located above the 
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heads of the patients. The exhausted air was equally balanced between the 
two diffusers.  
For the purpose of the experiment the headset incorporated wearable PV 
exhaust was simplified to test the effectiveness of the concept in evacuating 
the contaminated exhaled air: a circular exhaust nozzle (d = 0.03 m) attached 
to a flexible pipe and positioned on a stand in front of the doctor’s mouth, 
Fig. 2. A separate ventilation system was used to operate the PV unit. It 
consisted of the nozzle of circular cross-section, flexible pipe, reduction, 2 
dampers, 2 iris orifices and a fan in order to achieve the desired flow rate of 
0.25 L/s. The system was constructed outside the climate chamber, within 
the tall hall. The exhaled air captured by the wearable PV unit was exhausted 
directly into the total volume ventilation exhaust of the tall hall.  
 
a) 
 
b) 
 
c) 
Fig. 2  Headset incorporated wearable PV exhaust: a) conceptual design, b) tested nozzle 
geometry, c) simplified design 
The experiments without the headset device were performed at 3, 6 and 
12 ACH and were used as a reference. During the experiments with the 
headset the background ventilation in the chamber was set at 3 ACH. The 
headset was positioned 0.02 m from the mouth of the doctor, Fig. 2c. Room 
temperature was kept at 22˚C, while the relative humidity was not controlled 
but was measured to be between 30% and 40% during all experiments. 
Temperature and flow rate of supply and exhaust air, temperature inside the 
test room as well as the amount of air exhausted by the headset unit were 
recorded and controlled constantly to keep the set values. 
During all experiments R 134A tracer gas was used. It was dosed in the 
air exhaled by the breathing thermal manikin used to simulate the sick 
doctor. The dozed concentration of tracer gas was kept the same for all tested 
cases. The tracer gas was used to simulate airborne droplets and droplet 
nuclei of less than 2 µm aerodynamic diameter [12] that may carry one or 
many pathogens. The exhaled air from the manikin (doctor) was also heated 
to ensure a density close to that of air exhaled by a human being. In order to 
avoid transport of tracer gas (R 134A) from the surrounding hall, the 
experimental chamber was kept slightly over-pressurized at 1.6±0.2 Pa 
during all measurements.  
The tracer gas concentration was measured with two sets of multi gas 
sampler and analyzer based on the photo acoustic principle at 12 points: 1) in 
ventilation supply, 2) in exhaust over exposed patient 1, 3) in exhaust over 
the exposed patient 2, 4) at the mouth of the doctor, 5) at the mouth of the 
exposed patient, 6) at the centre of the room 1.7 m above the floor, 7) at the 
centre of the room 1.1 m above the floor, 8) at the centre of the room 0.1 m 
above the floor, 9) left from exposed patient 2 (0.55 m distance from the 
mouth) 1.7 m above the floor, 10) close to the feet of the sick patient 1.7 m 
above the floor, 11) close to the feet of the sick patient 1.1 m above the floor, 
Fig. 1. The twelfth measurement point was for measuring the concentration 
in the air exhausted by the headset. Therefore this point was used for the 
conditions that included the headset device. Neither the manikin simulating 
the exposed patient closest to the doctor (patient 1) nor the heated dummy 
(patient 2) was breathing. The sampling tube of R 134A was placed at the 
mouth 0.005 m away. As reported in the literature the tracer gas 
concentration measured in this way is equal to the tracer gas concentration in 
the air inhaled by the breathing thermal manikin [10]. 
2.1.  Experimental Procedure 
The air temperature in the laboratory hall and in the chamber was kept 
22 
o
C throughout the whole experiment. At the start of the experiments both 
thermal manikins and the dummy were switched on. For the experiments 
with headset the device was positioned in front of the mouth of the doctor at 
any of the three tested distances and the system exhausting the exhaled air 
was adjusted to the tested air flow rate. All measurements commenced after 
steady-state conditions were achieved, i.e. steady concentrations at centre of 
room and in both TV exhausts (located at the ceiling).  
After reaching a steady state, 15 sampled values for each measurement 
point were acquired.  
Temperature was measured throughout the experiments and after that a 
mean value was calculated for all the measurement locations. 
2.2. Analyses of Results 
The obtained tracer gas concentration data were normalized according to 
the following equation: 
ɛ = (Cm – Cs)/(Cm(3ACH) – Cs(3ACH))   (1) 
Cm – concentration acquired in the measuring location 
Cs – concentration acquired in total volume ventilation supply 
Cm(3ACH) – concentration in the measuring point at 3ACH (without 
headset) 
Cs(3ACH) – concentration in the total volume ventilation supply at 3ACH 
(without headset) 
 
3. Results 
The measured concentration of R 134A tracer gas and its normalized 
value are presented in Fig. 3. The following abbreviations are used in the 
legend of Fig. 3: ACH: air changes per hour, W/O: without, HS: headset. 
The abbreviations used to code the studied cases should be read as follows: 
1
st
 is the background ventilation level in the room, 2
nd
 comes the presence or 
absence of headset within the breathing zone of the occupant, 3
rd
 is the 
suction air flow of the headset unit tested and last, i.e. 4
th
, is distance of the 
unit from the mouth of the occupant wearing the headset. For example the 
abbreviation 3 ACH_HS 0.25 L/s_0.02 m should be understood as: 
background room ventilation is at 3 ACH, the occupant (doctor) is wearing 
the headset, which exhausts 0.25 L/s 0.02 m away from the mouth of the 
person (doctor). 
a)  
b)  
Fig. 3  a) Measured concentration values, b) Normalized concentration, when the doctor was 
without or with a headset exhausting at 0.25 L/s and 0.02 m distance from mouth standing near 
the head of EP1 and the room was ventilated at 3, 6 and 12 ACH 
The highest values of the concentrations were obtained at 3 ACH and 
decreased uniformly with increasing of the air change rate due to the 
increased dilution. Higher portion of the polluted air reached the exhaust 
over the exposed patient 1 (EP1) under all three conditions. This is due to the 
proximity of the doctor to the exhaust above patient 1 and the buoyancy 
effect that governed the spread of the air jet exhaled by the doctor. For the 
other measurement points the obtained concentrations maintained 
approximately equal level and were more than 50% lower than the 
concentration measured at the exhaust over EP1. Exception was the 
concentrations measured at the mouth of EP1, the values for which were 
slightly higher than for the other measurement locations for all three 
conditions. These results are explained by the fact that the doctor was close 
and facing EP1. The air distribution pattern in the room had a great impact. 
From performed visualizations with smoke generator, was seen that a 
recirculation zone was formed above the bed of EP1. It mixed the air exhaled 
by the doctor with the surrounding room air and brought it within the 
breathing zone of the lying patient. Nevertheless great portion of the exhaled 
air moved upwards especially at the lower flow rates of 3 and 6 ACH, parts 
of it spread in the room by the background airflow pattern. The exposure to 
exhaled air from a sick standing doctor was decreased more than 50% at 12 
ACH compared to 3 ACH, Figure 3b. However, at 6 ACH the reduction was 
much lower – around 30% and for some measurement points it didn’t 
exceeded 20%. It is noticed that the increase in the air change rate had the 
highest impact on the two exhausts since the normalized concentrations at 
these point were the lowest. This is due to the higher dilution of exhaled air 
when it reached the exhausts.  
When the headset was positioned at 0.02 m distance from the mouth of 
the doctor the measured and the normalized concentrations were lower or 
within the same range as at 12 ACH and without the headset. Clearly the use 
of local exhaust helped to reduce the spread of exhaled air in the room. The 
measured background concentration of exhaled air from a sick doctor was 
comparable or even lower than when ventilating with the recommended by 
the standards minimum of 12 ACH for isolation rooms. 
4. Discussion 
Creating healthy and comfortable environment in hospital premises is of 
great importance for fast recovery of patients, increase the performance of 
the medical personal and protection of both patients and medical staff from 
airborne cross infection. 
The results of the present study show that elevated ventilation rates 
corresponding to up to 12 ACH are not sufficient to protect the occupants 
(exposed patients) from airborne exposure to exhaled air by a sick medical 
staff member. Similar results apply for the case when the exposure to 
exhaled air comes from a sick lying patient [4, 5, 6]. The studies investigated 
the exposure to only one source, i.e. one sick patient. In case of pandemics, 
the density of the patients in hospitals will be higher than usual and 
consequently the risk of airborne cross infection will rise significantly. 
Relying only on total volume ventilation to effectively dilute the 
contaminated air and reduce the risk of cross infection is not enough and 
may not be possible. For example, increasing the number of sick patients to 
two in the same room, assuming that they both release the same amount of 
pathogens in the room air will require supply of twice more ventilation air to 
the room in order to achieve the same dilution as when the patient is alone. 
In case of isolation double bed room this will result to 24 ACH! Hence a new 
approach of ventilation is needed. The ultimate goal should be to provide 
better indoor environment and to reduce the risk of airborne cross-infection 
at reduced ventilation rate by more efficient air distribution than the mixing 
air distribution used in hospital wards today. 
The present paper shows that applying local control, i.e. exhausting 
expired air from within the breathing zone, can result in significantly reduced 
levels of exhaled air in hospital wards. This will result in lowered exposure 
of occupants to airborne pathogens and less supply air to dilute the room air. 
The concentrations of tracer gas measured at the mouth of the two patients 
and in the room were almost the same. The measured concentrations 
decreased with the increase of the ventilation rate. For the measurement with 
the headset the TV mixing ventilation was operated at 3 ACH. The use of the 
headset device showed that the background concentration in the measured 
locations was lowered to the level of 12 ACH and without the headset. It is 
important to be mentioned that the nozzle for this condition was placed 
0.02 m away from the doctor’s mouth.  
Simple calculation of the air supply flow rate by mixing ventilation at 12 
ACH and at 3 ACH but coupled with the headset operated at 0.25 L/s and for 
the volume of the occupied space equal to that of the climate chamber, i.e. 
57.4 m
3
, show that nearly 4 times more conditioned outdoor air needs to be 
supplied by the mixing ventilation alone at 12 ACH.  
To justify the use of the headset PV unit as local exhaust that can 
evacuate successfully expelled air more experiments are needed to study the 
impact of body movement, nozzle geometry, flowrate, distance from 
breathing zone etc. 
Previous research on the headset PV showed that the device is also very 
efficient in supplying clean air into the inhalation [4, 7, 9]. In practice, the 
headset can be made with a micro-pump (reversible to supply or exhaust the 
air) enclosed in a small casing with a mini-filter and mini-UVGI. The box 
can be worn attached to a belt around the waist of the user. The pump can be 
reversed and can start exhausting the exhaled air. Obviously further 
improvements in the design and airflow direction control of the headset are 
needed in order to be comfortable and not disturbing for wearing. Its small 
dimensions and simplicity will allow its application not only in hospital 
environment but in many densely occupied spaces: at reception desks, 
auditoriums, public transport services, airplanes etc. 
5. Conclusion 
The present study focused on the reduction in exposure to exhaled air by 
a “sick” doctor wearing headset incorporated exhaust device in a simulated 
double bed hospital room ventilated by mixing air distribution. The use of 
the headset as a local exhaust device at 3 ACH background ventilation rate 
reduced the exposure of the patients as well as the background tracer gas 
concentration below the levels registered at 12 ACH. 
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